{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:07:27Z","timestamp":1788887247667,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04417-1","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T21:20:03Z","timestamp":1739481603000},"page":"2271-2278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Analysis of antibiotic resistance and risk factors of extended-spectrum\u00a0beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections"],"prefix":"10.1007","volume":"57","author":[{"given":"Yuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"1","key":"4417_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1542\/peds.2015-0409","volume":"136","author":"R Keren","year":"2015","unstructured":"Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, Patel M, deBerardinis R, Parker A, Bhatnagar S et al (2015) Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics 136(1):13\u201321. https:\/\/doi.org\/10.1542\/peds.2015-0409","journal-title":"Pediatrics"},{"issue":"5","key":"4417_CR2","doi-asserted-by":"publisher","first-page":"682.e681","DOI":"10.1016\/j.jpurol.2022.09.012","volume":"18","author":"TH Horsager","year":"2022","unstructured":"Horsager TH, Hagstr\u00f8m S, Skals R (2022) Winding L: renal scars in children with febrile urinary tract infection\u2014looking for associated factors. J Pediatr Urol 18(5):682.e681-682.e689. https:\/\/doi.org\/10.1016\/j.jpurol.2022.09.012","journal-title":"J Pediatr Urol"},{"key":"4417_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310537","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y, Huang Y, Chi M (2023) Urinary tract infections caused by uropathogenic escherichia coli: mechanisms of infection and treatment options. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241310537","journal-title":"Int J Mol Sci"},{"issue":"10325","key":"4417_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Collaborators AR","year":"2022","unstructured":"Collaborators AR (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"issue":"12","key":"4417_CR5","first-page":"898","volume":"55","author":"The Subspecialty Group of Renal Diseases tSoP: Chinese Medical Association","year":"2017","unstructured":"The Subspecialty Group of Renal Diseases tSoP: Chinese Medical Association (2017) Evidence-based guideline on diagnosis and treatment of urinary tract infection (2016). Chinese J Pediatr 55(12):898\u2013901","journal-title":"Chinese J Pediatr"},{"issue":"8","key":"4417_CR6","first-page":"15","volume":"18","author":"S-H Wu","year":"2011","unstructured":"Wu S-H (2011) Practical clinical practice-pediatrics: diseases of the urinary system. Chinese Pract J Rural Doctor 18(8):15\u201321","journal-title":"Chinese Pract J Rural Doctor"},{"issue":"1","key":"4417_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","volume":"86","author":"J Kranz","year":"2024","unstructured":"Kranz J, Bartoletti R, Bruy\u00e8re F, Cai T, Geerlings S, K\u00f6ves B, Schubert S, Pilatz A, Veeratterapillay R, Wagenlehner FM, Bausch K (2024) European association of urology guidelines on urological infections: summary of the 2024 guidelines. Eur Urol 86(1):27\u201341. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.035","journal-title":"Eur Urol"},{"issue":"5","key":"4417_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3760\/j:issn:0376-2491","volume":"81","author":"Ministry of Health: People\u2019s Republic of China","year":"2001","unstructured":"Ministry of Health: People\u2019s Republic of China (2001) Diagnostic criteria for Hospital acquired infection(trial). Natl Med J China 81(5):314\u2013320. https:\/\/doi.org\/10.3760\/j:issn:0376-2491","journal-title":"Natl Med J China"},{"key":"4417_CR9","unstructured":"Clinical and Laboratory Standards Institute (2020) Performance standards for antimicrobial susceptibility testing; M100:30th edition. Vol.40 No.1."},{"issue":"10237","key":"4417_CR10","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/S0140-6736(20)30676-0","volume":"395","author":"K Tullus","year":"2020","unstructured":"Tullus K, Shaikh N (2020) Urinary tract infections in children. Lancet 395(10237):1659\u20131668. https:\/\/doi.org\/10.1016\/S0140-6736(20)30676-0","journal-title":"Lancet"},{"key":"4417_CR11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-012138","author":"TK Mattoo","year":"2021","unstructured":"Mattoo TK, Shaikh N, Nelson CP (2021) Contemporary management of urinary tract infection in children. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2020-012138","journal-title":"Pediatrics"},{"issue":"3","key":"4417_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1542\/peds.2011-1330","volume":"128","author":"KB Roberts","year":"2011","unstructured":"Roberts KB (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128(3):595\u2013610. https:\/\/doi.org\/10.1542\/peds.2011-1330","journal-title":"Pediatrics"},{"issue":"1","key":"4417_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkn444","volume":"63","author":"CG Giske","year":"2009","unstructured":"Giske CG, Sundsfjord AS, Kahlmeter G, Woodford N, Nordmann P, Paterson DL, Canton R, Walsh TR (2009) Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother 63(1):1\u20134. https:\/\/doi.org\/10.1093\/jac\/dkn444","journal-title":"J Antimicrob Chemother"},{"key":"4417_CR14","unstructured":"CDC. Antibiotic Resistance Threats in the United States (2019) U.S. Department of Health and Human Services: CDC; 2019. https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html"},{"issue":"11","key":"4417_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.15537\/smj.2019.11.24547","volume":"40","author":"L Keshi","year":"2019","unstructured":"Keshi L, Weiwei X, Shoulin L, Xiaodong L, Hao W, Junhai J, Xiangwei W, Rui W, Pei Z (2019) Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection. Saudi Med J 40(11):1111\u20131115. https:\/\/doi.org\/10.15537\/smj.2019.11.24547","journal-title":"Saudi Med J"},{"issue":"1","key":"4417_CR16","first-page":"53","volume":"24","author":"P Fen","year":"2024","unstructured":"Fen P, Chun W, Hong Z, Yang Y, Fupin H, Demei Z (2024) Changing antibiotic resistance profiles of enterobacterales strains isolated from children:data from CHINET Antimicrobial Resistance Surveillance Program:2015\u20132021. Chinese J Infect Chemother 24(1):53\u201363","journal-title":"Chinese J Infect Chemother"},{"issue":"7","key":"4417_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.medcli.2017.07.023","volume":"150","author":"G Jim\u00e9nez-Guerra","year":"2018","unstructured":"Jim\u00e9nez-Guerra G, Heras-Ca\u00f1as V, Molina LD, Sorl\u00f3zano-Puerto A, Navarro-Mar\u00ed JM, Guti\u00e9rrez-Fern\u00e1ndez J (2018) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: evolution of antimicrobial resistance and treatment options. Medi Clin 150(7):262\u2013265. https:\/\/doi.org\/10.1016\/j.medcli.2017.07.023","journal-title":"Medi Clin"},{"issue":"9","key":"4417_CR18","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s10096-024-04882-z","volume":"43","author":"AM Halld\u00f3rsd\u00f3ttir","year":"2024","unstructured":"Halld\u00f3rsd\u00f3ttir AM, Hrafnkelsson B, Einarsd\u00f3ttir K, Kristinsson KG (2024) Prevalence and risk factors of extended-spectrum beta-lactamase producing E. coli causing urinary tract infections in Iceland during 2012\u20132021. Eur J Clin Microbiol & Infect Dis 43(9):1689\u20131697. https:\/\/doi.org\/10.1007\/s10096-024-04882-z","journal-title":"Eur J Clin Microbiol & Infect Dis"},{"issue":"3","key":"4417_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jped.2016.06.009","volume":"93","author":"YH Kim","year":"2017","unstructured":"Kim YH, Yang EM, Kim CJ (2017) Urinary tract infection caused by community-acquired extended-spectrum \u03b2-lactamase-producing bacteria in infants. Jornal de Pediatria 93(3):260\u2013266. https:\/\/doi.org\/10.1016\/j.jped.2016.06.009","journal-title":"Jornal de Pediatria"},{"issue":"9","key":"4417_CR20","first-page":"964","volume":"60","author":"L Yi","year":"2022","unstructured":"Yi L, Xinglou L (2022) Strategies for selection and application of antibiotics for urinary tract infections in children. Chinese J Pediatr 60(9):964\u2013966","journal-title":"Chinese J Pediatr"},{"key":"4417_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01882-17","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, Xie L, Yang C, Ma X, Li H et al (2018) Epidemiology of carbapenem-resistant enterobacteriaceae infections: report from the China CRE network. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01882-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"48","key":"4417_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3346\/jkms.2023.38.e361","volume":"38","author":"KS Park","year":"2023","unstructured":"Park KS, Kim DR, Baek JY, Shin A, Kim KR, Park H, Son S, Cho H, Kim YJ (2023) Susceptibility to Fosfomycin and Nitrofurantoin of ESBL-positive Escherichia coli and Klebsiella pneumoniae isolated from urine of pediatric patients. J Korean Med Sci 38(48):361. https:\/\/doi.org\/10.3346\/jkms.2023.38.e361","journal-title":"J Korean Med Sci"},{"issue":"12","key":"4417_CR23","doi-asserted-by":"publisher","first-page":"e004152","DOI":"10.1136\/bmjopen-2013-004152","volume":"3","author":"LD Qiao","year":"2013","unstructured":"Qiao LD, Chen S, Yang Y, Zhang K, Zheng B, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, Yang WM (2013) Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study. BMJ Open 3(12):e004152. https:\/\/doi.org\/10.1136\/bmjopen-2013-004152","journal-title":"BMJ Open"},{"key":"4417_CR24","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3026","author":"INFECTION SOUT","year":"2016","unstructured":"INFECTION SOUT (2016) Reaffirmation of AAP clinical practice guideline: the diagnosis and management of the initial urinary tract infection in febrile infants and young children 2\u201324 months of age. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2016-3026","journal-title":"Pediatrics"},{"issue":"1","key":"4417_CR25","first-page":"1","volume":"47","author":"D Geleta","year":"2024","unstructured":"Geleta D, Abebe G, Alemu B, Workneh N, Beyene G (2024) Mechanisms of bacterial drug resistance with special emphasis on phenotypic and molecular characterization of extended spectrum beta-lactamase. New Microbiol 47(1):1\u201314","journal-title":"New Microbiol"},{"key":"4417_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49206","author":"R Niehus","year":"2020","unstructured":"Niehus R, van Kleef E, Mo Y, Turlej-Rogacka A, Lammens C, Carmeli Y, Goossens H, Tacconelli E, Carevic B, Preotescu L et al (2020) Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance. Elife. https:\/\/doi.org\/10.7554\/eLife.49206","journal-title":"Elife"},{"key":"4417_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1017\/S0950268820003015","volume":"149","author":"P Vachvanichsanong","year":"2020","unstructured":"Vachvanichsanong P, McNeil EB, Dissaneewate P (2020) Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections. Epidemiol Infect 149:12. https:\/\/doi.org\/10.1017\/S0950268820003015","journal-title":"Epidemiol Infect"},{"issue":"6","key":"4417_CR28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/j.1442-200X.2012.03709.x","volume":"54","author":"O Kizilca","year":"2012","unstructured":"Kizilca O, Siraneci R, Yilmaz A, Hatipoglu N, Ozturk E, Kiyak A, Ozkok D (2012) Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int 54(6):858\u2013862. https:\/\/doi.org\/10.1111\/j.1442-200X.2012.03709.x","journal-title":"Pediatr Int"},{"issue":"2","key":"4417_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"PD Tamma","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ (2022) Infectious Diseases Society of America 2022 Guidance on the treatment of extended-spectrum \u03b2-lactamase producing enterobacterales (ESBL-E): carbapenem-resistant enterobacterales (CRE): and pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis 75(2):187\u2013212. https:\/\/doi.org\/10.1093\/cid\/ciac268","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4417_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pedneo.2021.01.005","volume":"62","author":"KJ Jo","year":"2021","unstructured":"Jo KJ, Yoo S, Song JY, Kim SH, Park SE (2021) Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum \u03b2-lactamase-producing Escherichia coli. Pediatr Neonatol 62(3):271\u2013277. https:\/\/doi.org\/10.1016\/j.pedneo.2021.01.005","journal-title":"Pediatr Neonatol"},{"key":"4417_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlad021","author":"AC Branton","year":"2023","unstructured":"Branton AC, Vu CH, Venugopalan V, Santevecchi BA, Cherabuddi K, Ramphal R, Manohar T, Desear KE (2023) Re-evaluation of cefepime or piperacillin\/tazobactam to decrease use of carbapenems in ESBL-producing enterobacterales urinary tract infections (REDUCE-UTI). JAC-Antimicrob Resist. https:\/\/doi.org\/10.1093\/jacamr\/dlad021","journal-title":"JAC-Antimicrob Resist"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04417-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04417-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04417-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T08:16:11Z","timestamp":1749888971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04417-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4417"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04417-1","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study received approval from the Medical Ethics Review Committee of Anhui Provincial Children\u2019s Hospital: and informed consent was waived due to its retrospective design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}